Yahoo Web Search

Search results

1. • 

     3 Stocks That Can Help You to Get Richer in 2025 and Beyond

     Motley Fool via Yahoo Finance· 6 days ago

     (That's no accident, because a falling stock price will boost a dividend yield, and vice versa, and ...

2. • 

     BioNTech gets $145 million funding for African vaccine plants

     Reuters via Yahoo News· 23 hours ago

     FRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...

3. • Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org

     FactCheck.org· 7 days ago

     A rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...

4. • The growing promise of cancer vaccines

     Cosmos· 4 days ago

     A cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...

5. • 

     If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names

     InvestorPlace· 1 day ago

     Biotech stocks are not for the faint of heart. Between juggling FDA approvals, new product pipelines...

6. • 

     Obesity Drug Stocks: Where to Invest Now

     Morningstar· 2 days ago

     Pharmaceutical investing has seen huge moves in the industry’s stocks over the past year, with one area grabbing particular attention: obesity drugs....

7. • CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

     Morningstar· 7 days ago

     Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...

8. • 

     Semaglutide Significantly Improves Chronic Kidney Disease

     Medscape· 6 days ago

     "This is the first trial that's specifically asked the question of whether this class of drugs —...

9. • Exemestane Plus Ovarian Suppression Best in Early ILC

     Medscape· 6 days ago

     New data add to the body of evidence favoring the aromatase inhibitor therapy plus ovarian suppression over tamoxifen for premenopausal women with early invasive lobular carcinoma.

10. • 

      Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?

      Insider Monkey via Yahoo Finance· 3 days ago

      We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article...